Initiatives

Genome The Fertility Centre is a single stop Brand providing 360 degree fertility care for all fertility related issues and needs catering to couples facing challenges in achieving pregnancy. Genome has a highly qualified and trained team of dedicated embryologists and clinicians who have been trained exclusively in Reproductive Medicine at Israel with whose collaboration and technical knowledge the unit was established in 2006 in Kolkata. Genome over the years have continuously expanded from a single clinic to multi locational centres in Kolkata (2 centres), Medinipur, Bardhaman to begin with followed by plans of expansion in West Bengal & other states. Genome has an ambitious plan of rolling out many centres across Eastern India in coming years.

 

Oocyte Vitrification :

GENOME - The Fertility Centre now announces the availability of Oocyte Vitrification facilities from February, 2013 at its Kolkata Centre. Our Embryology team headed by Ms. Atreyee Chatterjee would be undergoing extensive training on this field prior to the initiation of this service. This process is ideal for ladies planning on late marriage or late pregnancies. Based on our protocols, occytes retrieved from their ovaries can be stored cryogenically which can later be thawed and used at a later date should the ladies need to go in for ART ever. The stored oocytes would help ladies plan their careers and families conveniently without having to worry about progressive deterioration of fertility with age. For further details, please get in touch with us at genomee@neotiahealthcare.com

IVM :

GENOME - The Fertility Centre announces the availability of IVM (In-Vitro Maturation) at its Kolkata centre from March, 2013 onwards. “In vitro oocyte maturation (IVM) permits the use of immature oocytes in IVF. IVM does not require ovarian stimulation and so can be offered to patients who are at risk of ovarian hyperstimulation syndrome. Immature oocyte recovery followed by in-vitro oocyte maturation and in vitro fertilization (IVF) is a promising new technology for the treatment of human infertility. The technology is attractive to potential oocyte donors, PCOS and infertile couples because of its reduced treatment intervention. Immature oocytes are recovered by ultrasound guided transvaginal follicular aspiration. Oocytes are matured in vitro for 36–48 h followed by intracytoplasmic sperm injection (ICSI). Embryos are cultured in vitro for 3 or 5 days before replacement. Assisted hatching is performed on a day 5 blastocyst stage embryo. This reduces the financial burden along with the reduced need of having to inject patients with hormones.” . For further details, please get in touch with us at genomee@neotiahealthcare.com

Endometrial Receptivity :

GENOME - The fertility centre is proud to announce a very critical addition in its service basket as part of its continuous process of upgrading its technical and clinical skills to ensure best results. “Endometrial receptivity is a self-limited period in which the endometrial epithelium acquires a functional and transient ovarian steroid-dependent status that allows blastocyst adhesion. Termed as ‘the window of implantation’, this specific period opens 4–5 days after progesterone production or administration and closes after 9–10 days. Scientific knowledge on the endometrial receptivity process is fundamental for the understanding of human reproduction. Would like to understand more on the work that you are doing on Endometrial Receptivity Assays and similar such techniques.” Clinicans from GENOME would be undergoing elaborate training at Israel on this field prior to this service being initiated in mid-2013. . For further details, please get in touch with us at genomee@neotiahealthcare.com

Reach Us